Gilbert S Omenn insider trades

Open-market stock purchases and sales by Gilbert S Omenn, Director at Amesite Inc, from SEC Form 4 filings since Dec 30, 2009.

Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -67%.

Recent trades

DateStockTradeValue
Sep 30, 2026AMST Amesite IncBought (not open market)—
Jun 30, 2026AMST Amesite IncBought (not open market)—
Mar 31, 2026AMST Amesite IncBought (not open market)—
Mar 7, 2026AMST Amesite IncBought (not open market)—
Feb 6, 2026AMST Amesite IncBought (not open market)—
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Dec 31, 2025AMST Amesite IncBought (not open market)—

Companies traded

  • AMST Amesite Inc: 4 buys, last Sep 30, 2026
  • GALT Galectin Therapeutics Inc: 2 buys, 2 sales, last Jan 16, 2026
  • ANGN Angion Biomedica Corp: other filings, last Jun 9, 2022
  • ESPR Esperion Therapeutics, Inc: 3 buys, last Apr 17, 2017
  • AMGN Amgen Inc: 1 sale, last Apr 25, 2014

Get free alerts when Gilbert S Omenn files a new trade →